The data illustrates the number of cancer drugs in development in the U.S. in select years between 2005 and 2018. As of May 2018, over 1,100 cancer drugs in development were reported. All of the medicines are either in clinical trials or awaiting review by the Food and Drug Administration (FDA).
2005 | 399 |
2006 | 646 |
2007 | 700 |
2008 | 750 |
2009 | 861 |
2011 | 887 |
2012 | 981 |
2014 | 771 |
2015 | 836 |
2018 | 1120 |